Skip to content

Chlorhexidine

ALIMENTARY TRACT AND METABOLISM

Also known as: chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine hydrochloride, chlorohex, chlorohexidine

OfpFDA approvedATC A01AB03ATC A01AB53ATC B05CA02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Chlorhexidine is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1976. DrugCentral lists 11 molecular targets, including SLC22A1, SLC22A2 and SLC22A3. Recorded indications include Gingivitis and Mouth Infection Prevention.

  • Approval status: ofp (first approved 1976 by the FDA).
  • Molecular targets: SLC22A1, SLC22A2, SLC22A3 and SLC47A2 (11 listed in DrugCentral).
  • Indications: Gingivitis and Mouth Infection Prevention.
  • ATC code: A01AB03 (Antiinfectives and antiseptics for local oral treatment).
  • Molecular formula: C22H30Cl2N10; molecular weight 505.45 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Gingivitis
  • Mouth Infection Prevention

Off-label uses (3)

  • Aphthous ulcer of mouth
  • Dental Plaque Prevention
  • Denture stomatitis

Contraindications (3)

  • Front Tooth Fillings
  • Open wound
  • Periodontitis

Mechanism & targets

Molecular targets (11)

TargetGeneActionActivity
Solute carrier family 22 member 1SLC22A1unknownIC50 6.68
Solute carrier family 22 member 2SLC22A2unknownIC50 6.40
Solute carrier family 22 member 3SLC22A3unknownIC50 6.39
Multidrug and toxin extrusion protein 2SLC47A2unknownIC50 6.30
Multidrug and toxin extrusion protein 1SLC47A1unknownIC50 6.15
Trypanothione reductaseTPRunknownKi 5.70
CAAX prenyl protease 2RCE1unknownAC50 5.24
72 kDa type IV collagenaseMMP2unknownIC50 5.12
Matrix metalloproteinase-9MMP9unknownIC50 5.12
Dual specificity protein kinase CLK2CLK2unknownIC50 5.04
Synaptojanin-2SYNJ2unknownIC50 5.00

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1976-09-17FDA—MOLNLYCKE HLTH

ATC classification

ATC codeTherapeutic hierarchy
A01AB03ALIMENTARY TRACT AND METABOLISM › STOMATOLOGICAL PREPARATIONS › STOMATOLOGICAL PREPARATIONS › Antiinfectives and antiseptics for local oral treatment
A01AB53ALIMENTARY TRACT AND METABOLISM › STOMATOLOGICAL PREPARATIONS › STOMATOLOGICAL PREPARATIONS › Antiinfectives and antiseptics for local oral treatment
B05CA02BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › IRRIGATING SOLUTIONS › Antiinfectives
D08AC02DERMATOLOGICALS › ANTISEPTICS AND DISINFECTANTS › ANTISEPTICS AND DISINFECTANTS › Biguanides and amidines
D08AC52DERMATOLOGICALS › ANTISEPTICS AND DISINFECTANTS › ANTISEPTICS AND DISINFECTANTS › Biguanides and amidines
D09AA12DERMATOLOGICALS › MEDICATED DRESSINGS › MEDICATED DRESSINGS › Medicated dressings with antiinfectives
R02AA05RESPIRATORY SYSTEM › THROAT PREPARATIONS › THROAT PREPARATIONS › Antiseptics
S01AX09SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Other antiinfectives
S02AA09SENSORY ORGANS › OTOLOGICALS › ANTIINFECTIVES › Antiinfectives
S03AA04SENSORY ORGANS › OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS › ANTIINFECTIVES › Antiinfectives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Folliculitis3866.2
Muscle injury3453.5
Irritable bowel syndrome3406.5
Impaired healing3270.7
Sleep disorder due to general medical condition, insomnia type2879.4
Lower respiratory tract infection2872.5
Blister2640.3
Helicobacter infection2561.6
Duodenal ulcer perforation2506.7
Ill-defined disorder2502.2
Stomatitis2475.2
Gastrointestinal disorder2060.3

Chemical structure

Molecular formulaC22H30Cl2N10
Molecular weight505.45 g/mol
CAS number55-56-1
InChIKeyGHXZTYHSJHQHIJ-UHFFFAOYSA-N
PubChem CID9552079
ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Chlorhexidine used for?

DrugCentral lists the following indications for Chlorhexidine: Gingivitis and Mouth Infection Prevention.

How does Chlorhexidine work?

Its molecular targets in DrugCentral include SLC22A1, SLC22A2, SLC22A3 and SLC47A2.

When was Chlorhexidine first approved?

Chlorhexidine was first approved by the FDA in 1976.

What is the chemical formula of Chlorhexidine?

Chlorhexidine has the molecular formula C22H30Cl2N10 and a molecular weight of 505.45 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1976-09-17
AgencyFDA
Targets11
Indications2
FormulaC22H30Cl2N10
DrugCentral ID597
Interactive profile